By analysing the robustness of ER systems in response to the regulation of HDM and HDAC activity, we present a model of ER capable of formulating strategies aimed at modifying the aging process and the aging-dependency of cancer, based on the control of epigenetic resilience and plasticity. The gene discussed is HDAC9; the disease is cancer.